Topiramate

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 72888-230
  • Package NDC 72888-230-05
  • Package NDC 72888-230-12
  • Package NDC 72888-230-30
  • Package NDC 72888-230-60
  • Package NDC 72888-230-67
  • Application number ANDA216683
  • SPL ID 4e8dd02d-2263-78d0-e063-6294a90a5f0b
  • SPL set ID 48169bbc-4fb2-4bc4-9bdd-de71bf7722df
  • UNII 0H73WJJ391
  • RxCUI 205315
  • RxCUI 205316
  • RxCUI 252413

What the source publishes

Labeler
Advagen Pharma Ltd
Active ingredients
Topiramate
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:72888-230_4e8dd02d-2263-78d0-e063-6294a90a5f0b
{
  "name": "Topiramate",
  "splId": "4e8dd02d-2263-78d0-e063-6294a90a5f0b",
  "labels": [
    {
      "setId": "48169bbc-4fb2-4bc4-9bdd-de71bf7722df",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=48169bbc-4fb2-4bc4-9bdd-de71bf7722df",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=48169bbc-4fb2-4bc4-9bdd-de71bf7722df"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Advagen Pharma Ltd",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "500 CAPSULE in 1 BOTTLE (72888-230-05)",
      "package_ndc": "72888-230-05",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250527"
    },
    {
      "sample": false,
      "description": "120 CAPSULE in 1 BOTTLE (72888-230-12)",
      "package_ndc": "72888-230-12",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250527"
    },
    {
      "sample": false,
      "description": "30 CAPSULE in 1 BOTTLE (72888-230-30)",
      "package_ndc": "72888-230-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250527"
    },
    {
      "sample": false,
      "description": "60 CAPSULE in 1 BOTTLE (72888-230-60)",
      "package_ndc": "72888-230-60",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250527"
    },
    {
      "sample": false,
      "description": "240 CAPSULE in 1 BOTTLE (72888-230-67)",
      "package_ndc": "72888-230-67",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250527"
    }
  ],
  "productId": "72888-230_4e8dd02d-2263-78d0-e063-6294a90a5f0b",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "72888-230",
  "deaSchedule": null,
  "genericName": "Topiramate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TOPIRAMATE",
      "strength": "50 mg/1"
    }
  ],
  "applicationNumber": "ANDA216683",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20250527",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000008486",
      "N0000185506",
      "N0000182140"
    ],
    "upc": [
      "0372888228051",
      "0372888230672",
      "0372888228679",
      "0372888229126",
      "0372888229676",
      "0372888230054",
      "0372888228129",
      "0372888228303",
      "0372888229607",
      "0372888230122",
      "0372888228600",
      "0372888229058",
      "0372888230603",
      "0372888230306"
    ],
    "unii": [
      "0H73WJJ391"
    ],
    "rxcui": [
      "205315",
      "205316",
      "252413"
    ],
    "spl_set_id": [
      "48169bbc-4fb2-4bc4-9bdd-de71bf7722df"
    ],
    "pharm_class_pe": [
      "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "pharm_class_moa": [
      "Cytochrome P450 3A4 Inducers [MoA]",
      "Cytochrome P450 2C19 Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Advagen Pharma Ltd"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:72888-230_4e8dd02d-2263-78d0-e063-6294a90a5f0b"